American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| 1 |
iShares Russell 1000 Growth ETF
IWF
|
+$544M |
| 2 |
Apple
AAPL
|
+$224M |
| 3 |
Exxon Mobil
XOM
|
+$219M |
| 4 |
Meta Platforms (Facebook)
META
|
+$189M |
| 5 |
CRH
CRH
|
+$177M |
Top Sells
| 1 |
UnitedHealth
UNH
|
+$402M |
| 2 |
Colgate-Palmolive
CL
|
+$255M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$235M |
| 4 |
Starbucks
SBUX
|
+$175M |
| 5 |
Equinix
EQIX
|
+$168M |
Sector Composition
| 1 | Technology | 27.37% |
| 2 | Financials | 12.82% |
| 3 | Healthcare | 11.58% |
| 4 | Consumer Discretionary | 11.43% |
| 5 | Industrials | 9.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2651
Joby Aviation
JOBY
$12B
| $216K | ﹤0.01% |
42,376
| – | – |
|
2652
Amneal Pharmaceuticals
AMRX
$3.14B
| $212K | ﹤0.01% |
33,314
-192,743
| -85% | -$1.22M |
|
2653
Nurix Therapeutics
NRIX
$691M
| $211K | ﹤0.01% |
10,124
-49,942
| -83% | -$1.04M |
|
2654
Weyco Group
WEYS
$280M
| $210K | ﹤0.01% |
6,912
| – | – |
|
|
BITF
2655
Bitfarms
BITF
$1.23B
| $208K | ﹤0.01% |
80,690
-17,063
| -17% | -$44K |
|
2656
GameStop
GME
$11.2B
| $207K | ﹤0.01% |
+8,366
| New | +$207K |
|
2657
AeroVironment
AVAV
$12.1B
| $206K | ﹤0.01% |
+1,133
| New | +$206K |
|
2658
Caribou Biosciences
CRBU
$168M
| $205K | ﹤0.01% |
125,029
+16,530
| +15% | +$27.1K |
|
2659
Syndax Pharmaceuticals
SNDX
$1.34B
| $201K | ﹤0.01% |
+9,803
| New | +$201K |
|
|
NNDM
2660
Nano Dimension
NNDM
$309M
| $201K | ﹤0.01% |
91,429
| – | – |
|
2661
ReposiTrak
TRAK
$311M
| $200K | ﹤0.01% |
+13,054
| New | +$200K |
|
2662
Blink Charging
BLNK
$153M
| $200K | ﹤0.01% |
72,840
+28,265
| +63% | +$77.4K |
|
2663
Solid Biosciences
SLDB
$420M
| $196K | ﹤0.01% |
34,557
+9,853
| +40% | +$55.9K |
|
2664
Sutro Biopharma
STRO
$74.3M
| $196K | ﹤0.01% |
66,812
-6,803
| -9% | -$19.9K |
|
2665
QuickLogic
QUIK
$92.3M
| $196K | ﹤0.01% |
18,841
+3,750
| +25% | +$39K |
|
2666
Pitney Bowes
PBI
$1.96B
| $195K | ﹤0.01% |
38,427
+27
| +0.1% | +$137 |
|
2667
Pyxis Oncology
PYXS
$113M
| $193K | ﹤0.01% |
58,252
+20,901
| +56% | +$69.2K |
|
2668
CS Disco
LAW
$357M
| $192K | ﹤0.01% |
32,180
+4,632
| +17% | +$27.6K |
|
2669
Sportsman's Warehouse
SPWH
$117M
| $191K | ﹤0.01% |
79,426
+19,237
| +32% | +$46.4K |
|
2670
Sotera Health
SHC
$4.56B
| $188K | ﹤0.01% |
15,852
-601
| -4% | -$7.13K |
|
2671
Krispy Kreme
DNUT
$541M
| $185K | ﹤0.01% |
+17,181
| New | +$185K |
|
2672
Monte Rosa Therapeutics
GLUE
$297M
| $185K | ﹤0.01% |
49,410
+15,562
| +46% | +$58.2K |
|
2673
Pulmonx
LUNG
$69.3M
| $184K | ﹤0.01% |
28,954
+1,272
| +5% | +$8.06K |
|
2674
Shattuck Labs
STTK
$92M
| $183K | ﹤0.01% |
47,367
+9,608
| +25% | +$37.1K |
|
2675
GrowGeneration
GRWG
$103M
| $182K | ﹤0.01% |
84,823
+12,197
| +17% | +$26.2K |
|